OPW
ABBV icon

Oxler Private Wealth’s AbbVie ABBV Stock Holding History

Oxler Private Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.77M Buy
17,314
+121
+0.7% +$26.8K 1.18% 21
2025
Q4 		$3.93M Buy
17,193
+119
+0.7% +$27.1K 1.14% 19
2025
Q3 		$3.95M Buy
17,074
+72
+0.4% +$14.7K 1.15% 20
2025
Q2 		$3.16M Buy
17,002
+147
+0.9% +$27.3K 0.99% 22
2025
Q1 		$3.53M Buy
16,855
+140
+0.8% +$27.2K 1.24% 23
2024
Q4 		$2.97M Buy
16,715
+44
+0.3% +$8.09K 0.98% 23
2024
Q3 		$3.29M Buy
16,671
+133
+0.8% +$24.8K 1.15% 23
2024
Q2 		$2.84M Buy
16,538
+158
+1% +$26.2K 1.05% 24
2024
Q1 		$2.98M Buy
16,380
+13,122
+403% +$2.26M 1.17% 22
2023
Q4 		$505K Sell
3,258
-12,788
-80% -$1.86M 0.42% 42
2023
Q3 		$2.39M Buy
16,046
+142
+0.9% +$20.8K 1.2% 24
2023
Q2 		$2.14M Sell
15,904
-42
-0.3% -$6.16K 1.02% 28
2023
Q1 		$2.54M Buy
15,946
+151
+1% +$23.1K 1.25% 24
2022
Q4 		$2.55M Buy
+15,795
New +$2.42M 1.37% 25
2022
Q3 		– Sell
-15,495
Closed -$2.37M – 435
2022
Q2 		$2.37M Buy
15,495
+149
+1% +$22.8K 1.14% 26
2022
Q1 		$2.49M Buy
15,346
+148
+1% +$21.5K 1.12% 25
2021
Q4 		$2.06M Hold
15,198
– – 0.85% 33
2021
Q3 		$1.64M Hold
15,198
– – 0.72% 38
2021
Q2 		$1.71M Hold
15,198
– – 0.75% 41
2021
Q1 		$1.64M Buy
15,198
+4,473
+42% +$478K 0.83% 34
2020
Q4 		$1.15M Buy
+10,725
New +$1.03M 0.65% 36

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Oxler Private Wealth's ABBV Position: Q1 2026 in Review

Oxler Private Wealth increased its AbbVie (ABBV) stake by 0.7% in Q1 2026, buying an estimated $26.8K and bringing the position to 17,314 shares worth $3.77M. The position accounts for 1.18% of the portfolio, ranked #21.

Oxler Private Wealth first reported a position in ABBV in Q4 2020 and has held it in 21 quarters since. The position peaked at $3.95M in Q3 2025. 4,078 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Oxler Private Wealth held 17,314 shares of AbbVie worth $3.77M as of Q1 2026.
  • Oxler Private Wealth bought 121 AbbVie shares in Q1 2026, an estimated $26.8K.
  • AbbVie made up 1.18% of Oxler Private Wealth's portfolio in Q1 2026, its #21 holding.
  • Oxler Private Wealth first reported a position in AbbVie in Q4 2020 and has held it in 21 quarters since.
  • Oxler Private Wealth's AbbVie position peaked at $3.95M in Q3 2025.
  • 4,078 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Oxler Private Wealth's 13F filing for Q1 2026, filed 28 Apr 2026.